CLINICAL_TRIALS
trial_result
· 2017-02-27
Clinical Trial Update: Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants [Phase 4]
Summary
Phase 4 trial update provides dosing chart guidance for calculating the first dose of doxapram in premature infants with apnea of prematurity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jean Michel Hascoet | Conditions: Premature Infants, Apnea | Phase 4 | Status: COMPLETED